2006 Clinical Trials Consumption Data 
Project CBD
MARCH 21, 2023
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
The Cannigma
FEBRUARY 22, 2021
To get their results, the researchers, who were primarily from the US’s National Institutes of Health (NIH), looked at select data from a clinical trial that investigated the effects of aspirin in pregnant women. The participants’ levels of cannabis use were determined via questionnaires and urine samples. “The
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
FEBRUARY 22, 2021
To get their results, the researchers, who were primarily from the US’s National Institutes of Health (NIH), looked at select data from a clinical trial that investigated the effects of aspirin in pregnant women. The participants’ levels of cannabis use were determined via questionnaires and urine samples. “The
Greencamp
AUGUST 16, 2018
The first study I will reference is from 2006, conducted on mice. Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.”.
Cannabis Law Report
OCTOBER 29, 2019
The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
CannaMD
OCTOBER 7, 2019
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Stimulating CB1 receptors with THC results in up-regulation across the board (meaning most patients will experience an increase in appetite and calorie consumption). Believe it or not, science says: YES.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Cell Calcium 39 (2006) 155–162.
Expert insights. Personalized for you.
144 
Let's personalize your content